维普期刊资源整合服务平台（V6.5）

维普中文期刊产品整合服务

8篇 您的检索式：作者名="L Simkens"

选中清除导出查看参考文献查看引证文献引用追踪共1页首页上一页第1页下一页末页 /1 跳转

		题名	作者	年代	出处	被引量
	1	Maintenance treatment with capecitabine and bevacizumab in metastatic colorectal cancer (CAIRO3) : a phase 3 randomised controlled trial of the Dutch Colorectal Cancer Group 显示文摘	SIMKENS L H VAN TINTEREN H MAY A	2015	Lancet2015，385，9980：	1
	2	Maintenance treat- merit with capecitabine and bevacizumab in metastatic colorec- tal cancer (CAIRO3): a phase 3 randomised controlled trial of the Dutch Colorectal Cancer Group显示文摘	Simkens L H van Tinteren H May A	2015	Lancet2015，385，9980：	1
	3	Final results and subgroup analyses of the phase 3 CAIR03 study:Maintenance treatment with capecitabine and bevacizumab versus observation after induction treatment with chemotherapy and bevacizumab in metastatic colorectal cancer(mCRC)显示文摘	KOOPMAN M SIMKENS L MAY A	2014	J Clin Oncol2014，32，3：	1
	4	Final results and subgroup analyses of the phase 3 CAIRO3 study: Maintenance treatment with Capeeitabine and Bevacizumab versus observation after induction treatment with chemotherapy and Bevacizumab in metastatic colorectal cancer (mCRC)显示文摘	Koopman M Simkens L May A	2014	J Clin Oncol2014，32，3：	1
	5	Final results and subgroup analyses of the phase 3 CAIRO3 study: Maintenance treatment with Capecitabine + Bevacizumab versus observation after induction treatment with chemotherapy + Bevacizumab in metastatic colorectal cancer (mCRC)显示文摘	Koopman M Simkens L May AM	2014	J Clin Oncol2014，32，15：	1
	6	Outcomes of colorectal cancer patients with peritoneal carcinomatosis treated with chemotherapy with and without targeted therapy显示文摘	KLAVER Y L SIMKENS L H LEMMENS V E	2012	Eur J Surg Oncol2012，38，7：	1
	7	Maintenance treatment with capecitabine and bevacizumab versus observation after induction treatment with chemotherapy and bevacizumab in metastatic colorectal cancer(mCRC):The phase Ⅲ CAIRO3 study of the Dutch Colorectal Canccr Group (DCCG)显示文摘	Miriam Koopman L Simkens A ten Tije	2013	J Clin Oncol2013，，：	1
	8	Final results and sub- group analyses of the phase 3 CAIRO3 study: maintenance treatment with capecitabine + bevacizumab versus observation after induction treatment with chemotherapy + bevacizumab in metastatic colorectal cancer (mCRC)显示文摘	Koopman M Simkens L May AM et at	2014	J Clin Oncol2014，32，5：	1

返回顶部每页显示：

共1页首页上一页第1页下一页末页 /1 跳转

goolge学术搜索-维普

网站首页 | 关于我们 | 联系我们 | 产品服务 | 客服中心 | 广告服务 | 版权声明 | 网站联盟 | 友情链接 | 售卡网点

版权所有© 渝B2-20050021-1　渝公网安备 50019002500403号　违法和不良信息举报中心

互联网出版许可证新出网证(渝)字10号全国400电话 - 免长途话费